RxDoctor Payments Data

Beatriz Mateus, MD

Psychiatry · Phoenix, AZNPI 1417021486

Payments from drug & device makers

$472in general payments, 2019–2025

Across 19 payments — averaging $24.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$168
  • Teva Pharmaceuticals USA, Inc.$75
  • Alkermes, Inc.$63
  • Johnson & Johnson$59
  • Neurocrine Biosciences, Inc.$50
  • Indivior Inc.$21
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$42590%
  • Education$4710%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$472 in reported general payments places this provider in the 60th percentile of 573 psychiatry providers in Arizona.

See all psychiatry providers in Arizona

Medicare billing

Part B allowed, 2024
$15,274
Medicare patients
19
Services billed
150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate209$754,109
AristadaAripiprazole Lauroxil96$310,322
Abilify MaintenaAripiprazole98$262,398
Clozapine763$20,768
TrintellixVortioxetine Hydrobromide61$11,542
RexultiBrexpiprazole18$10,492
Fluphenazine Decanoate66$7,277
Fluphenazine Hcl42$6,814
Divalproex Sodium ErDivalproex Sodium83$6,389
Aripiprazole77$4,704
Haloperidol Decanoate111$4,047
Trazodone Hcl427$3,520
Propranolol Hcl218$3,169
Benztropine Mesylate358$3,154
Haloperidol129$3,146

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$59$754,109209 claims
Alkermes, Inc.Aristada$63$310,32296 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$20$272,890116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 573 psychiatry providers in Arizona.

Other psychiatry in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →